- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Large Mammography Study Reaffirms Benefits of Digital Breast Tomosynthesis
In a recent video interview, Emily Conant, M.D., discussed findings from a large multicenter study highlighting the benefits of digital breast tomosynthesis (DBT) in breast cancer screening.
In a study involving over 2.5 million screening mammograms for over one million women, researchers found a significantly higher cancer detection rate and lower recall rate for digital breast tomosynthesis (DBT) in comparison to digital mammography (DM).
For the retrospective multicenter study, recently published in Radiology, researchers reviewed 2,528,063 screening mammograms for 1,100,447 women (mean age of 57). According to the study, 597,947 women had a total of 1,693,727 DBT screening exams and 502,500 women had a total of 834,336 DM screening exams.
The study authors found that DBT had a higher cancer detection rate (5.3/1000) in comparison to DM (4.5/1000) and a higher positive predictive value (5.9 percent vs. 4.3 percent). Researchers also noted a lower recall rate for DBT (8.9 percent vs. 10.3 percent for DM).
In a recent interview, Emily Conant, M.D., the lead author of the study, said the findings were similar to those noted in other studies of DBT but seeing the findings in a large, diverse multicenter cohort reaffirmed the advantages of DBT over two-dimensional (2D) mammography. She added that DBT also provides enhanced visualization for cancer detection in women with dense breasts.
“2D mammography, as we know, is very limited in (women with dense breasts) because the breast just appears white. That dense breast tissue obscures finding things,” noted Dr. Conant, the division chief of breast imaging and a professor of radiology at the Hospital of the University of Pennsylvania. “When you can scroll through these slices of reconstructed images of the breast, you can actually find things on (digital breast) tomosynthesis that you didn’t see on 2D mammography because it was just a white blizzard of breast density.”
(Editor’s note: For related content, see “Mammography Study Shows 22 Percent Higher Incidence of Dense Breasts in Women with a Family History of Breast Cancer,” “AI Improves Cancer Detection Rate for Digital Mammography and Digital Breast Tomosynthesis” and “FDA Issues Final Rule on National Breast Density Notification for Mammography Reports.”)
For more insights from Dr. Conant, watch the video below.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.
